Cardiac – Heart Issues
Severe Ischemic Heart Disease
Heart Attack Pain Reduuction
Atherosclerosis of the heart and lower Extremities
thesis plan master click phd thesis motivation pdf buy litrature review art essay help persuasive essay examples for elementary students pacific oil company case study https://efm.sewanee.edu/faq/how-to-solve-statistics-math-problems/22/ extrinsic motivation on academic achievement research paper cialis sale london why dose viagra cost so fucking much easybib the things they carried click here viagra ice cream selfridges orlistat sandoz 120 mg in usa ap english comparison essay thesis headings apa style thesis gender roles coumadin imuran what a literature review is and why it is important best selling food writer female viagra follow link https://smartfin.org/science/cialis-utisci/12/ flagyl 200 mg syrup essay on importance of technical education see url cialis online prescription soma usa viagra 4000 liquid viagra buy le levitra efficace https://ramapoforchildren.org/youth/essay-global-warming-short/47/ xatral levitra Severe Ischemic Heart Disease
This study consisted of 70 males , ranging from 32 to 79 years old. All patients suffered from angina pectoris, 56 had a heart attack previous to the study. These men had already failed to recover using intensive drug therapy. Seven treatments of UBI were given with no toxic effects noted. All of the patients were observed for 2-16 months.
- All patients were able to reduce nitroglycerin
- Stenocardia was reduced
- 46 were able to walk 1 km per day
- 31 of 39 who had jobs were able to return to work
- 7 patients died – 6 were over 60yrs old, 3 over 70
The results were assessed “outstanding” considering the serious condition of the patients. Improvement was attributed to improvements in microcirculation, vasodilation and oxygenation of the blood. There was also an effect of humoral immunity, lessening the postinfarct cardiosclerosis.
Intercardial LBI was administered during severe heart attacks. Thirty patients received five to seven treatments, twenty received drug treatment. With the LBI stabilizing effect, power analgesic effect (33% pain was totally suppressed and 22% significantly reduced) narcotics were reduced to 1/8 of normal levels and analgesics to 1/3. After 2-3 hours LBI patients with intense pain was only 15% while with drugs the level was 45%. There were no complications with the LBI therapy.
Also, marked improvement in rheological properties of the blood. Viscosity dropped 30%, platelet aggregation by 25%, fribogen level by 20% leading to a 35% reduction in in general peripheral resistance and normalization of diastolic pressure. Stabilization of hemodynamic levels and more rapid resolution of the heath attack. This maintained for the 6 months of follow-up.
UBI within 6 hours of heart attack – 24 patients received drugs and UBI – 21 registered analgesic effect, 1 patient died. Following UBI incidents of extrasystole decreased sharply then tended to increase after 12-24 hours necessitating another UBI treatment. No increase of arrhythmia occurred in fact UBI had an anti-arrhythmic effect, possibly because of the anti-ischemic action.
There are multiple miscellaneous studies in the collection by Ganelina, “Mechanisms of the Influence of Blood…”.
Unpublished report but observations and case studies recorded the positive effects of UBI on acute coronary occlusion and congestive heart failure. Quick use of UBI led to improved microcirculation and reduced inflammation of the heart muscle, reduced pain, cyanosis and dyspnea. UBI given every few days usually led to overall improvement even with those who appeared to be terminal.
(Miley, “Ultraviolet Blood Irradiation…”)
Atherosclerosis of the heart and lower Extremities – Beneficial Effects of UBI
- Improved rheological characteristics of the blood
- Improved microcirculation
- Increased oxygenation of the blood
- Raised levels of cholesterol and beta-lipoproteins
They then studied the impact of UBI on the patient’s enzymes. A control group of 13 healthy male and 54 patients were observed in the study. Out of these patients, 25 had ischematic heart disease and 29 ischemic disease of the lower limbs. During the study, 15 heart and 11 lower limb patients received UBI (5 to 10 sessions). It was documented that 12 of the 15 heart patients and 8 of the 11 lower limb patients benefited substantially.
In conclusion, UBI should be dosed with care in elderly, lest it activate lipid peroxidation that could be harmful. Best results from younger and earlier stage patients.
Severe Ischemic heart disease
Severe ischemic heart disease was present in 145 males. Patients received 5 to 10 treatments of UBI along with standard drugs. Out of 145, 137 had favorable response to UBI and overall condition improved. Fewer analgesics or nitroglycerin tablets. It was documented that 92 patients had fewer incidents of stenocardia and could walk 1,000 meters per day. The other 45 saw moderate improvement. Researchers felt UBI regularized biochemical substances and function in the body.
Dozens of other studies are listed in the above collection.
Another study consisted of 45 unstable stenocardia patients. Out of these patients, 26 were diagnosed with post-infarction cardiosclerosis and were observed against a control group. After 5 to 7 treatments, 45 patients underwent improvement in general condition, less weakness, reduced headaches and insomnia, reduced nitrates, and other listed benefits.